Atherosclerotic peripheral vascular disease symposium II vascular magnetic resonance and computed tomographic imaging

Circulation

Volumn 118, Issue 25, 2008, Pages 2837-2844

  Josephs, Shellie C ^a   Rowley, Howard A ^a   Rubin, Geoffrey D ^a  

^a NONE

Author keywords

AHA conference proceedings; Cerebrovascular disorders; Imaging; Magnetic resonance imaging; Peripheral vascular disease

Indexed keywords

ALTEPLASE; DESMOTEPLASE; GADOLINIUM; IODINATED CONTRAST MEDIUM; IODIXANOL;

ATHEROSCLEROSIS; CAROTID ARTERY BIFURCATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST INDUCED NEPHROPATHY; DIAGNOSTIC IMAGING; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; STROKE;

AMERICAN HEART ASSOCIATION; ATHEROSCLEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; PERIPHERAL VASCULAR DISEASES; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 58249136300     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.191173     Document Type: Conference Paper

References (65)

1. Rubin GD, Shiau MC, Leung AN, Kee ST, Logan LJ, Sofilos MC. Aorta and iliac arteries: single versus multiple detector-row helical CT angiography. Radiology. 2000;215:670-676.
2. Willmann JK, Wildermuth S, Pfammatter T, Roos JE, Seifen B, Hilfiker PR, Marincek B, Weishaupt D. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology. 2003;226:798-811.
3. Ota H, Takase K, Igarashi K, Chiba Y, Haga K, Saito H, Takahashi S. MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images. AJR Am J Roentgenol. 2004;182:201-209.
4. Fishman EK, Ney DR, Heath DG, Corl FM, Horton KM, Johnson PT. Volume rendering versus maximum intensity projection in CT angiography: what works best, when, and why. Radiographies. 2006;26:905-922.
5. McDougal JL, Valentine RJ, Josephs S, Trimmer C, Clagett GP, Modrall JG. Computed lomographic angiography has added value in patients with vascular disease. J Vasc Surg. 2006;44:998-1001.
6. Mallouhi A, Rieger M, Czermak B. Freund MC, Waldenberger P, Jaschke WR. Volume-rendered multidetector CT angiography: noninvasive follow-up of patients treated with renal artery stents. AJR Am J Roentgenol. 2003;180:233-239.
7. Willmann JK, Baumert B, Schertler T, Wildermuth S, Pfammatter T, Verdun FR, Seifert B, Marincek B, Böhm T. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography. Radiology. 2005;236:1083-1093.
8. Hurwitz LM, Yoshizumi TT, Reiman RE, Paulson EK, Frush DP, Nguyen GT, Toncheva GI, Goodman PC. Radiation dose to the female breast from 16-MDCT body protocols. AJR Am J Roentgenol. 2006;186:1718-1722.
9. Morcos SK. Prevention of contrast media-induced nephrotoxicity after angiographic procedures. J Vasc Interv Radiol. 2005;16:13-23.
10. Rudnick M, Goldberg S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: a randomized trial. Kidney Int. 1995;47:254-261.
11. Aspelin P, Aubry P, Fransson S-G, Strasser R, Willenbrock R, Berg KJ; for the NEPHRIC Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-499.
12. Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M. Wilensky RL, O'Neill WW; CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290:2284-2291.
13. Spinazzi A, Pozzi Mucelli R. Administration of iodinated contrast in patients with pre-existing renal failure: a review. Radiol Med (Torino). 2004;107:88-97.
14. Du J, Fain SB, Korosec FR, Grist TM, Mistretta CA. Time-resolved contrast-enhanced carotid imaging using undersampled projection reconstruction acquisition. J Magn Reson Imaging. 2007;25:1093-1099.
15. Hagspiel KD, Yao L, Shih M-CP, Burkholder B, Bissonette E, Harthun NL. Comparison of multistation MR angiography with integrated parallel acquisition technique versus conventional technique with a dedicated phased-array coil system in peripheral vascular disease. J Vasc Interv Radiol. 2006;17:263-269.
16. Yang CW, Carr JC, Futterer SF, Morasch MD, Yang BP, Shors SM, Finn JP. Contrast-enhanced MR angiography of the carotid and vertebrobasilar circulations. AJNR Am J Neuroradiol. 2005;26:2095-2101.
17. Westwood ME, Kelly S, Berry E, Bamford JM, Gough MJ, Airey CM, Meaney JF, Davies LM, Cullingworth J, Smith MA. Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review. BMJ. 2002;324:198-202.
18. Wang Y, Winchester PA, Khilnani NM, Lee HM, Watts R, Trost DW, Bush HL Jr, Kent KC, Prince MR. Contrast-enhanced peripheral MR angiography from the abdominal aorta to the pedal arteries: combined dynamic two-dimensional and bolus-chase three-dimensional acquisitions. Invest Radiol. 2001;36:170-177.
19. Wardlaw JM, Chappell FM, Best JJ, Wartolowska K, Berry E; NHS Research and Development Health Technology Assessment Carotid Stenosis Imaging Group. Non-invasive imaging compared with intraarterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet. 2006;367:1503-1512.
20. Collins R, Burch J, Cranny G, Aguiar-Ibáñez R, Craig D, Wright K, Berry E, Gough M, Kleijnen J, Westwood M. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ. 2007;334:1257-1265.
21. Wieben O, Grist TM, Hany TF, Thornton FJ, Glaser JK, Skuldt DH, Block WF. Time-resolved 3D MR angiography of the abdomen with a real-time system. Magn Reson Med. 2004;52:921-926.
22. Remy-Jardin M, Bahepar J, Lafitte J-J, Dequiedt P, Ertzbischoff O, Bruzzi J, Delannoy-Deken V, Duhamel A, Remy J. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients. Radiology. 2006;238:1022-1035.
23. Spinosa DJ, Kaufmann JA, Hartwell GD. Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology. 2002;223:319-325.
24. Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD, Cage D, Bissonette EA, Koenig KG, Ayers CR, McConnell K. Safety of CO2- and gadodiamide-enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal insufficiency. AJR Am J Roentgenol. 2001;176:1305-1311.
25. US Food and Drug Administration, Center for Drug Evaluation and Research, Public Health Advisory. Gadolinium-Containing Contrast Agents for Magnetic Resonance Imaging (MRI): Omniscan, OptiMARK, Magnevist, ProHance, and MultiHance. Available at: http://www.fda.gov/cder/drug/advisory/ gadolinium_agents.htm. Accessed September 8, 2006.
26. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW, Gilk T, Gimbel JR, Gosbee J, Kuhni-Kaminski E, Lester JW Jr, Nyenhuis J, Parag Y, Schaefer DJ, Sebek-Scoumis EA, Weinreb J, Zaremba LA, Wilcox P, Lucey L, Sass N; ACR Blue Ribbon Panel on MR Safety. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol. 2007;188:1447-1474.
27. Sam AD II, Morasch MD, Collins J, Song G, Chen R, Pereles FS. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg. 2003;38:313-318.
28. Thomsen HS. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol. 2004;14:1654-1656.
29. Ergün I, Keven K, Uruç I, Ekmekçi Y, Canbakan B, Erden I, Karatan O. The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant. 2006;21:697-700.
30. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
31. Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD; North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339:1415-1425.
32. Willinsky RA, Taylor SM, TerBrugge K, Farb RI, Tomlinson G, Montanera W. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology. 2003;227:522-528.
33. Hacklander T, Wegner H, Hoppe S, Danckworth A, Kempkes U, Fischer M, Mertens H, Caldwell JH. Agreement of multislice CT angiography and MR angiography in assessing the degree of carotid artery stenosis in consideration of different methods of postprocessing. J Comput Assist Tomogr. 2006;30:433-442.
34. Josephson SA, Bryant SO, Mak HK, Johnston SC, Dillon WP, Smith WS. Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology. 2004;63:457-460.
35. Schlaug G, Benfield A, Baird AE, Siewert B, Lovblad KO, Parker RA, Edelman RR, Warach S. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology. 1999;53:1528-1537.
36. Hjort N, Butcher K, Davis SM, Kidwell CS, Koroshetz WJ, Röther J, Schellinger PD, Warach S, Østergaard L; UCLA Thrombolysis Investigators. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke. 2005;36:388-397.
37. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, Pineda C, Serena J, van der Schaaf I, Waaijer A, Anderson J, Nesbit G, Gabriely I, Medina V, Quiles A, Pohlman S, Quist M, Schnyder P, Bogousslavsky J, Dillon WP, Pedraza S. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006;37:979-985.
38. Wintermark M, Meuli R, Browaeys P, Reichhart M, Bogousslavsky J, Schnyder P, Michel P. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology. 2007;68:694-697.
39. Fisher M, Hanley DF, Howard G, Jauch EC, Warach S; STAIR Group. Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke. 2007;38:245-248.
40. Rowley HA. Extending the time window for thrombolysis: evidence from acute stroke trials. Neuroimaging Clin N Am. 2005;15:575-587.
41. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W; DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227-1231.
42. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S; DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66-73.
43. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517.
44. Köhrmann M, Jüttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol. 2006;5:661-667.
45. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J, Zaro Weber O, Kucinski T, Juettler E, Ringleb PA, Zeumer H, Weiller C, Hacke W, Schellinger PD, Röther J; MRI in Acute Stroke Study Group of the German Competence Network Stroke. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke. 2006;37:852-858.
46. Anzalone N, Scomazzoni F, Castellano R, Strada L, Righi C, Politi LS, Kirchin MA, Chiesa R, Scotti G. Carotid artery stenosis: intraindividual correlations of 3D time-of-flight MR angiography, contrast-enhanced MR angiography, conventional DSA, and rotational angiography for detection and grading. Radiology. 2005;236:204-213.
47. Cosottini M, Pingitore A, Puglioli M, Michelassi MC, Lupi G, Abbruzzese A, Calabrese R, Lombardi M, Parenti G, Bartolozzi C. Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making. Stroke. 2003;34:660-664.
48. Goyal M, Nicol J, Gandhi D. Evaluation of carotid artery stenosis: contrast-enhanced magnetic resonance angiography compared with conventional digital subtraction angiography. Can Assoc Radiol J. 2004;55:111-119.
49. Smith WS, Roberts HC, Chuang NA, Ong KC, Lee TJ, Johnston SC, Dillon WP. Safety and feasibility of a CT protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. AJNR Am J Neuroradiol. 2003;24:688-690.
50. Walker LJ, Ismail A, McMeekin W, Lambert D, Mendelow AD, Birchall D. Computed tomography angiography for the evaluation of carotid atherosclerotic plaque: correlation with histopathology of endarterectomy specimens. Stroke. 2002;33:977-981.
51. Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 1994;344:237-239.
52. Eardley KS, Lipkin GW. Atherosclerotic renal artery stenosis: is it worth diagnosing? J Hum Hypertens. 1999;13:217-220.
53. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608-1616.
54. Choudhri AH, Cleland JG, Rowlands PC, Tran TL, McCarthy M, Al-Kutoubi M. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ. 1990;301:1197-1198.
55. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135:401-411.
56. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, Maki JH, Leiner T, Beek FJ, Korst MB, Flobbe K, de Haan MW, van Zwam WH, Postma CT, Hunink MG, de Leeuw PW, van Engelshoven JM; for the Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-682.
57. Fraioli F, Catalano C, Bertoletti L, Danti M, Fanelli F, Napoli A, Cavacece M, Passariello R. Multidetector-row CT angiography of renal artery stenosis in 50 consecutive patients: prospective interobserver comparison with DSA. Radiol Med (Torino). 2006;111:459-468.
58. Berg MH, Manninen HI, Vanninen RL, Vainio PA, Soimakallio S. Assessment of renal artery stenosis with CT angiography: usefulness of multiplanar reformation, quantitative stenosis measurements, and densitometric analysis of renal parenchymal enhancement as adjuncts to MIP film reading. J Comput Assist Tomogr. 1998;22:533-540.
59. Beregi JP, Louvegny S, Gautier C, Mounier-Vehier C, Moretti A. Desmoucelle F, Wattinne L, McFadden E. Fibromuscular dysplasia of the renal arteries: comparison of helical CT angiography and arteriography. AJR Am J Roentgenol. 1999;172:27-34.
60. Rubin GD, Schmidt AJ, Logan U, Sofilos MC. Multi-detector row CT angiography of lower extremity arterial inflow and runoff: initial experience. Radiology. 2001;221:146-158.
61. Catalano C, Fraioli F, Laghi A, Napoli A, Bezzi M, Pediconi F, Danti M, Nofroni I, Passariello R. Infrarenal aortic and lower-extremity arterial disease: diagnostic performance of multi-detector row CT angiography. Radiology. 2004;231:555-563.
62. Martin ML, Tay KH, Flak B, Fry PD, Doyle DL, Taylor DC, Hsiang YN, Machan LS. Multidetector CT angiography of the aortoiliac system and lower extremities: a prospective comparison with digital subtraction angiography. AJR Am J Roentgenol. 2003;180:1085-1091.
63. Ofer A, Nitecki SS, Linn S, Epelman M, Fischer D, Karram T, Litmanovich D, Schwartz H, Hoffman A, Engel A. Multidetector CT angiography of peripheral vascular disease: a prospective comparison with intraarterial digital subtraction angiography. AJR Am J Roentgenol. 2003;180:719-724.
64. Portugaller HR, Schoellnast H, Hausegger KA, Tiesenhausen K, Amann W, Berghold A. Multislice spiral CT angiography in peripheral arterial occlusive disease: a valuable tool in detecting significant arterial lumen narrowing? Eur Radiol. 2004;14:1681-1687.
65. Lapeyre M, Kobeiter H, Desgranges P, Rahmouni A, Becquemin J-P, Luciani A. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. Am J Roentgenol. 2005;185:1641-1650.